InterAct Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $250K in debt securities (Form D filed Jul 21, 2026). SEC Form D 0002107143-26-000001 (Jul 21, 2026)
  Evidence (1 event)

  • Jul 21, 2026 · SEC Form D 0002107143-26-000001
    Name of Issuer: InterAct Therapeutics, Inc.; CIK: 2107143; Address: Dallas, TX; Submission type: D; Filing date: 2026-07-21; Industry Group: Other Health Care; Date of First Sale: 2026-07-20; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 250000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals